Calibrating real-world evidence studies against randomized trials: Treatment effectiveness of infliximab in inflammatory bowel disease

被引：0
|
作者：
Kirchgesner, Julien [1 ,2 ]
Desai, Rishi J. [1 ,2 ]
Schneeweiss, Maria C. [1 ,2 ]
Beaugerie, Laurent [3 ]
Kim, Seoyoung C. [1 ,2 ]
Schneeweiss, Sebastian [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Sorbonne Univ, Hop St Antoine, AP HP,Dept Gastroenterol, INSERM,Inst Pierre Louis Epidemiol & Sante Publ, Paris, France
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：41 / 42
页数：2
相关论文
共 50 条
  • [1] Calibrating Real-World Evidence Studies Against Randomized Trials: Treatment Effectiveness of Infliximab in Crohn's Disease
    Kirchgesner, Julien
    Desai, Rishi J.
    Beaugerie, Laurent
    Kim, Seoyoung C.
    Schneeweiss, Sebastian
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (01) : 179 - 186
  • [2] Real-world experience with subcutaneous infliximab: broadening treatment strategies for inflammatory bowel disease
    Smith, Philip J.
    Fumery, Mathurin
    Leong, Rupert W.
    Novak, Kerri
    Dignass, Axel
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (09) : 1143 - 1156
  • [3] Effectiveness of switching from intravenous to subcutaneous infliximab in Inflammatory Bowel Disease patients: A combined analysis of real-world evidence
    Cummings, F.
    Buisson, A.
    Smith, P. J.
    Rahmany, S.
    Subramanian, S.
    Kwon, B.
    Park, S.
    Lee, Y. N.
    Fumery, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1332 - I1333
  • [4] PRECISION DOSING TEST IN OPTIMIZING INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE: A REAL-WORLD EVIDENCE STUDY
    Abraham, Bincy P.
    Fatima, Ayesha
    Battat, Robert J.
    Carroll, Kristin
    Torres, Esther A.
    Rabizadeh, Shervin
    Ziring, David
    Gohndrone, Judith
    Lum, Donald
    Arai, Ronen
    Ali, Tauseef
    Allen, Mark J.
    Condino, Adria A.
    Stein, Daniel J.
    Pandey, Akash
    Barrett, Terrence
    Ritter, Timothy E.
    Bray, Harry
    Hanauer, Stephen B.
    Dervieux, Thierry
    Colombel, Jean Frederic
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S1111 - S1111
  • [5] Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease
    Brian Bressler
    Jennifer Jones
    Tracy S. H. In
    Tommy Lan
    Cristian Iconaru
    John K. Marshall
    [J]. Advances in Therapy, 2023, 40 : 4421 - 4439
  • [6] Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease
    Bressler, Brian
    Jones, Jennifer
    In, Tracy S. H.
    Lan, Tommy
    Iconaru, Cristian
    Marshall, John K.
    [J]. ADVANCES IN THERAPY, 2023, 40 (10) : 4421 - 4439
  • [7] Emulation Differences vs. Biases When Calibrating Real-World Evidence Findings Against Randomized Controlled Trials
    Franklin, Jessica M.
    Glynn, Robert J.
    Suissa, Samy
    Schneeweiss, Sebastian
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (04) : 735 - 737
  • [8] Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort
    Plevris, N.
    Chuah, C. S.
    Allen, R. M.
    Arnott, I. D.
    Brennan, P. N.
    Chaudhary, S.
    Churchhouse, A. M. D.
    Din, S.
    Donoghue, E.
    Gaya, D. R.
    Groome, M.
    Jafferbhoy, H. M.
    Jenkinson, P. W.
    Lam, W. L.
    Lyons, M.
    Macdonald, J. C.
    MacMaster, M.
    Mowat, C.
    Naismith, G. D.
    Potts, L. F.
    Saffouri, E.
    Seenan, J. P.
    Sengupta, A.
    Shasi, P.
    Sutherland, D. I.
    Todd, J. A.
    Veryan, J.
    Watson, A. J. M.
    Watts, D. A.
    Jones, G. R.
    Lees, C. W.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 (09): : 1111 - 1120
  • [9] MULTIPLE BIOSIMILAR INFLIXIMAB SWITCHING IS NOT ASSOCIATED WITH DISEASE FLARE IN INFLAMMATORY BOWEL DISEASE: A REAL-WORLD EFFECTIVENESS ANALYSES IN A NATIONAL US COHORT
    Hou, Jason
    Pham, Codey
    Xu, Anthony
    Sansgiry, Shubhada
    Modi, Varsha
    Waljee, Akbar
    [J]. INFLAMMATORY BOWEL DISEASES, 2024, 30 : S7 - S7
  • [10] Real-world subcutaneous infliximab for inflammatory bowel disease: A systematic review and meta-analysis
    Chetwood, J.
    Tran, Y.
    Subramanian, S.
    Smith, P.
    Iborra Colomino, M.
    Buisson, A.
    Paramsothy, S.
    Leong, R.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 160 - 161
12345